ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MRSN Mersana Therapeutics Inc

3,46
0,10 (2,98%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:08:01
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Mersana Therapeutics Inc MRSN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,10 2,98% 3,46 23:08:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,52 3,42 3,63 3,46 3,36
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
02.5.202414:00GLOBEMersana Therapeutics to Host First Quarter 2024 Conference..
04.4.202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
28.2.202422:08EDGAR2Form 8-K - Current report
28.2.202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.2.202422:05EDGAR2Form POS AM - Post-Effective amendments for registration..
28.2.202414:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28.2.202414:43EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
28.2.202413:07EDGAR2Form 8-K - Current report
28.2.202413:00GLOBEMersana Therapeutics Provides Business Update and..
27.2.202414:01GLOBEMersana Therapeutics to Present at Upcoming Investor..
21.2.202414:00GLOBEMersana Therapeutics to Host Fourth Quarter and Year End..
16.2.202422:30EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15.2.202402:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15.2.202402:43EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202414:00GLOBEMersana Therapeutics to Participate in Guggenheim’s 6th..
17.1.202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202403:14EDGAR2Form 144 - Report of proposed sale of securities
17.1.202403:13EDGAR2Form 144 - Report of proposed sale of securities
17.1.202403:13EDGAR2Form 144 - Report of proposed sale of securities
12.1.202422:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
05.1.202414:06EDGAR2Form 8-K - Current report
05.1.202414:01GLOBEMersana Therapeutics Announces Business Updates, Expected..
04.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:11EDGAR2Form 8-K - Current report
01.12.202322:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
07.11.202314:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:18EDGAR2Form 8-K - Current report
07.11.202313:00GLOBEMersana Therapeutics Provides Business Update and Announces..
31.10.202321:30GLOBEMersana Therapeutics to Host Third Quarter 2023 Conference..
31.10.202317:59DJNMersana Therapeutics Shares Rise 8% After FDA Lifts Clinical..
31.10.202314:07DJNMersana Says FDA Lifts Clinical Hold on Gastric-Cancer..
31.10.202313:12EDGAR2Form 8-K - Current report
31.10.202313:00GLOBEMersana Therapeutics Announces FDA has Lifted Clinical Hold..
27.10.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202314:27EDGAR2Form 8-K - Current report
07.9.202323:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202323:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock